DEFINITIVE NOTICE AND PROXY

Company

Inhibitor Therapeutics, Inc.

Filed

January 8, 2007

Period of Report

January 9, 2007

Accession Number

0001193125-07-002829

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →